What is the difference between loperamide and racecadotril for treating acute diarrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Racecadotril vs Loperamide for Treating Acute Diarrhea

Loperamide is generally preferred over racecadotril for treating acute diarrhea in adults due to its established efficacy, safety profile, and wider availability, though racecadotril may cause less constipation. 1, 2

Mechanism of Action

  • Loperamide: Acts as an opioid receptor agonist with local activity in the gut and minimal systemic absorption, reducing intestinal motility and peristalsis, thereby decreasing stool frequency, urgency, and volume 1
  • Racecadotril: Functions as an enkephalinase inhibitor with antisecretory activity that does not significantly affect intestinal transit time 3

Efficacy

  • Both medications demonstrate similar efficacy in resolving acute diarrhea, with comparable duration of diarrhea (approximately 13-19 hours) and similar clinical success rates (>90%) 4, 3
  • Loperamide has been shown to reduce stool weight, frequency of bowel movements, urgency, and fecal incontinence in both acute and chronic diarrhea 1
  • Racecadotril produces significant decreases in stool weight compared to placebo during the first day of treatment 5

Side Effect Profiles

  • Loperamide:

    • More likely to cause rebound constipation (18.7-29% vs 9.8-12.9% with racecadotril) 4, 3
    • Risk of paralytic ileus with high doses, requiring monitoring 1
    • Potential for serious cardiac adverse reactions including QT prolongation and Torsades de Pointes with higher than recommended doses 6
  • Racecadotril:

    • Lower incidence of constipation compared to loperamide 4, 3
    • May cause itching in some patients (28.6% in one study) 3
    • Generally well-tolerated with adverse event profile similar to placebo 5

Dosing

  • Loperamide: Initial dose of 4 mg followed by 2 mg every 2-4 hours or after every unformed stool, with maximum daily dose of 16 mg 1
  • Racecadotril: Typically administered as 100 mg three times daily 4, 3

Special Considerations

Age Restrictions

  • Loperamide is FDA-approved for patients 2 years of age and older 6
  • Loperamide is contraindicated in children under 2 years due to risks of respiratory depression and cardiac adverse reactions 6
  • The Infectious Diseases Society of America strongly recommends against antimotility drugs in children under 18 years with acute diarrhea 1, 2

Contraindications

  • Both drugs should be avoided in cases where inhibition of peristalsis could lead to complications such as ileus, megacolon, or toxic megacolon 6
  • Loperamide should be avoided in suspected or proven cases of inflammatory diarrhea or diarrhea with fever 1, 2
  • Loperamide should be used with caution in patients with cardiac conditions or taking medications that prolong QT interval 6

Clinical Algorithm for Selection

  1. First priority: Ensure adequate hydration before considering antimotility agents 1, 2

  2. For uncomplicated acute watery diarrhea in adults:

    • Loperamide is first-line due to established efficacy and wider availability 2, 7
    • Consider racecadotril if patient has history of constipation or is at risk for complications from constipation 4, 3
  3. Avoid both medications in:

    • Children under 18 years (especially loperamide in those under 2 years) 1, 2, 6
    • Patients with bloody diarrhea or high fever 1, 2
    • Cases of suspected inflammatory bowel conditions 6
  4. For immunotherapy-induced diarrhea: Both racecadotril and loperamide are recommended for grade 1 diarrhea, but should be avoided in grade 3-4 diarrhea 1

Key Pitfalls to Avoid

  • Never use antimotility agents before ensuring adequate hydration 1, 2
  • Avoid loperamide in patients with inflammatory diarrhea or fever due to risk of toxic megacolon 1, 2
  • Monitor patients on high-dose loperamide for signs of paralytic ileus 1
  • Be aware that loperamide at higher than recommended doses can cause serious cardiac adverse reactions 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Appropriate Use of Anti-Motility Agents in Diarrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Comparison of racecadotril and loperamide in adults with acute diarrhoea.

Alimentary pharmacology & therapeutics, 1999

Research

Racecadotril versus placebo in the treatment of acute diarrhoea in adults.

Alimentary pharmacology & therapeutics, 1999

Research

Safety and efficacy of loperamide.

The American journal of medicine, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.